BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35061986)

  • 1. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
    Chen WC; Lafreniere M; Phuong C; Liu SJ; Baal JD; Lometti M; Morin O; Ziemer B; Vasudevan HN; Lucas CG; Hervey-Jumper SL; Theodosopoulos PV; Magill ST; Fogh S; Nakamura JL; Boreta L; Sneed PK; McDermott MW; Raleigh DR; Braunstein SE
    J Neurosurg; 2022 Oct; 137(4):924-930. PubMed ID: 35061986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
    Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
    J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
    Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
    J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
    Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
    J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cesium-131 brachytherapy in brain tumors: a scoping review of the literature and ongoing clinical trials.
    Palmisciano P; Haider AS; Balasubramanian K; D'Amico RS; Wernicke AG
    J Neurooncol; 2022 Aug; 159(1):117-133. PubMed ID: 35696019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
    Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
    Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.
    Koch MJ; Agarwalla PK; Royce TJ; Shih HA; Oh K; Niemierko A; Mauceri TC; Curry WT; Barker FG; Loeffler JS
    Neurosurgery; 2019 Nov; 85(5):E910-E916. PubMed ID: 31329941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
    Imber BS; Young RJ; Beal K; Reiner AS; Giantini-Larsen AM; Krebs S; Yang JT; Aramburu-Nunez D; Cohen GN; Brennan C; Tabar V; Moss NS
    J Neurooncol; 2022 Sep; 159(3):609-618. PubMed ID: 35896906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
    Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
    Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.
    Hallemeier CL; You YN; Larson DW; Dozois EJ; Nelson H; Klein KA; Miller RC; Haddock MG
    Dis Colon Rectum; 2014 Apr; 57(4):442-8. PubMed ID: 24608300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-Irradiation Using Brachytherapy for Recurrent Intracranial Tumors: A Systematic Review and Meta-Analysis of the Literature.
    Choi M; Zabramski JM
    Cureus; 2020 Aug; 12(8):e9666. PubMed ID: 32923261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
    J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.
    Bander ED; Kelly A; Ma X; Christos PJ; Wernicke AG; Stieg PE; Trichter S; Knisely JPS; Ramakrishna R; Schwartz TH
    J Neurooncol; 2023 Jun; 163(2):355-365. PubMed ID: 37249824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
    Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
    Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial.
    Nakaji P; Smith K; Youssef E; Thomas T; Pinnaduwage D; Rogers L; Wallstrom G; Brachman D
    Cureus; 2020 Nov; 12(11):e11570. PubMed ID: 33224684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
    J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.